Korai biomarkerek használata a prevencióban. Az expozíció, a korai hatás és az egyéni érzékenység markerei

Translated title of the contribution: The use of early biomarkers in prevention. The markers of the exposition, early effect and individual sensitivity

I. Ember, Kiss István, J. Sándor, Fehér Katalin, Németh Katalin, Lukács Péter

Research output: Contribution to journalArticle

Abstract

The molecular and predictive epidemiology plays more and more important role in the prevention of cancer. With the help of early biomarkers, high risk population could be identified for primary preventive intervention modalities. It uses both molecular biological methods and elements of risk assessment plus a testing system based on animal experiments. Its specificity is not high enough to establish the diagnosis but it can be used to monitor the disease and to follow the effectivity of the therapy (e.g. "minimal residual disease") and the preventive interventions. It is also suitable for risk assessment with the markers of individual susceptibility. As to everyday practice there are many problems because of limited therapeutic possibilities, but we hope that the molecular and predictive epidemiology becomes an important part of medicine in the near future.

Original languageHungarian
Pages (from-to)547-554
Number of pages8
JournalLege Artis Medicinae
Volume13
Issue number7
Publication statusPublished - Oct 2003

Fingerprint

Molecular Epidemiology
Biomarkers
Residual Neoplasm
Medicine
Therapeutics
Population
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Korai biomarkerek használata a prevencióban. Az expozíció, a korai hatás és az egyéni érzékenység markerei. / Ember, I.; István, Kiss; Sándor, J.; Katalin, Fehér; Katalin, Németh; Péter, Lukács.

In: Lege Artis Medicinae, Vol. 13, No. 7, 10.2003, p. 547-554.

Research output: Contribution to journalArticle

Ember, I. ; István, Kiss ; Sándor, J. ; Katalin, Fehér ; Katalin, Németh ; Péter, Lukács. / Korai biomarkerek használata a prevencióban. Az expozíció, a korai hatás és az egyéni érzékenység markerei. In: Lege Artis Medicinae. 2003 ; Vol. 13, No. 7. pp. 547-554.
@article{728a3d99d72b466ea34e717785e4d841,
title = "Korai biomarkerek haszn{\'a}lata a prevenci{\'o}ban. Az expoz{\'i}ci{\'o}, a korai hat{\'a}s {\'e}s az egy{\'e}ni {\'e}rz{\'e}kenys{\'e}g markerei",
abstract = "The molecular and predictive epidemiology plays more and more important role in the prevention of cancer. With the help of early biomarkers, high risk population could be identified for primary preventive intervention modalities. It uses both molecular biological methods and elements of risk assessment plus a testing system based on animal experiments. Its specificity is not high enough to establish the diagnosis but it can be used to monitor the disease and to follow the effectivity of the therapy (e.g. {"}minimal residual disease{"}) and the preventive interventions. It is also suitable for risk assessment with the markers of individual susceptibility. As to everyday practice there are many problems because of limited therapeutic possibilities, but we hope that the molecular and predictive epidemiology becomes an important part of medicine in the near future.",
keywords = "Early biological effect, Early biomarkers, Exposition, High risk population, Molecular and predictive epidemiology, Risk assessment",
author = "I. Ember and Kiss Istv{\'a}n and J. S{\'a}ndor and Feh{\'e}r Katalin and N{\'e}meth Katalin and Luk{\'a}cs P{\'e}ter",
year = "2003",
month = "10",
language = "Hungarian",
volume = "13",
pages = "547--554",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "7",

}

TY - JOUR

T1 - Korai biomarkerek használata a prevencióban. Az expozíció, a korai hatás és az egyéni érzékenység markerei

AU - Ember, I.

AU - István, Kiss

AU - Sándor, J.

AU - Katalin, Fehér

AU - Katalin, Németh

AU - Péter, Lukács

PY - 2003/10

Y1 - 2003/10

N2 - The molecular and predictive epidemiology plays more and more important role in the prevention of cancer. With the help of early biomarkers, high risk population could be identified for primary preventive intervention modalities. It uses both molecular biological methods and elements of risk assessment plus a testing system based on animal experiments. Its specificity is not high enough to establish the diagnosis but it can be used to monitor the disease and to follow the effectivity of the therapy (e.g. "minimal residual disease") and the preventive interventions. It is also suitable for risk assessment with the markers of individual susceptibility. As to everyday practice there are many problems because of limited therapeutic possibilities, but we hope that the molecular and predictive epidemiology becomes an important part of medicine in the near future.

AB - The molecular and predictive epidemiology plays more and more important role in the prevention of cancer. With the help of early biomarkers, high risk population could be identified for primary preventive intervention modalities. It uses both molecular biological methods and elements of risk assessment plus a testing system based on animal experiments. Its specificity is not high enough to establish the diagnosis but it can be used to monitor the disease and to follow the effectivity of the therapy (e.g. "minimal residual disease") and the preventive interventions. It is also suitable for risk assessment with the markers of individual susceptibility. As to everyday practice there are many problems because of limited therapeutic possibilities, but we hope that the molecular and predictive epidemiology becomes an important part of medicine in the near future.

KW - Early biological effect

KW - Early biomarkers

KW - Exposition

KW - High risk population

KW - Molecular and predictive epidemiology

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=0344014124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344014124&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0344014124

VL - 13

SP - 547

EP - 554

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 7

ER -